22Nov/13

Investors Alert: Amgen, Inc. (NASDAQ:AMGN), Galena Biopharma Inc (NASDAQ … – Market News Call

Investors Alert: Amgen, Inc. (NASDAQ:AMGN), Galena Biopharma Inc (NASDAQ
Market News Call
18 announced that the company’s Phase 3 study (Study 116) evaluating idelalisib in combination with rituximab in previously-treated chronic lymphocytic leukemia (CLL) patients who were not fit for chemotherapy was accepted for presentation during a 

and more »

22Nov/13

Obama Signs Law Allowing Organ Donation Between HIV-Positive Patients – Towleroad


Jagran Post

Obama Signs Law Allowing Organ Donation Between HIV-Positive Patients
Towleroad
Last week we reported that Congress had passed the HIV Organ Policy Equity (HOPE) Act, a bill that will end a 25-year ban on using HIV-positive donors’ organs for any purpose, including medical research. It will also lift the ban on the donation of
New law allows HIV-infected organ donationBaltimore Sun (blog)
Obama signs bill allowing scientists to carry out research in HIV organ donationJagran Post
Obama signs bill for HIV organ donationNewstrack India
Economic Times
all 71 news articles »
22Nov/13

Research and Markets: Congestive Heart Failure (Heart Failure) – Pipeline … – The Herald | HeraldOnline.com (press release)

Research and Markets: Congestive Heart Failure (Heart Failure) – Pipeline
The Herald | HeraldOnline.com (press release)
‘Congestive Heart Failure (Heart Failure) – Pipeline Review, H2 2013′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Congestive Heart Failure (Heart Failure), complete

and more »